Overview of therapeutic and disease areas

UCB has created three divisions to focus on severe diseases treated by specialists, covering three main therapeutic areas: neurology, inflammatory diseases including autoimmune diseases and oncology.

In addition to its clinical development pipeline, UCB has nine new molecules in late stage research or pre-clinical development.